Barrett Esophagus
Return to Library
|
Free Barrett Esophagus Articles |
|
|
|
|
New barrett esophagus data have been reported by L. Robertson and co-authors
2009 JUL 13 - (NewsRx.com) -- According to a study from the United States, "Barrett's esophagus is a premalignant metaplastic process that involves the distal esophagus and requires lifelong surveillance and treatment, One of the major risk factors identified (sic) development of Barrett's esophagus is gastroesophageal reflux disease, which is reported in up to 20% of the adult population in the United States." "New mucosal ablative techniques have emerged to treat Barrett's esophagus with high-grade dysplasia in an effort to prevent the progression to esophageal adenocarcinoma. Esophageal cancer is the 7th most prevalent cancer in the world and has a very poor 5-year survival rate," wrote L. Robertson and colleagues. The researchers concluded: "This review focuses on the developments in the field of Barrett's esophagus including the epidemiology, presentation and progression, medical and surgical management, recommendations for treatment, guidelines for surveillance, and new therapeutic treatments." Robertson and colleagues published the results of their research in Gastroenterology Nursing (A New Horizon Recommendations and Treatment Guidelines for Barrett's Esophagus. Gastroenterology Nursing, 2009;32(3):202-210). For additional information, contact L. Robertson, York Hospital, Dept. of Gastroenterology, 1001 S George St., York, PA 17356, USA. The publisher of the journal Gastroenterology Nursing can be contacted at: Lippincott Williams & Wilkins, 530 Walnut St., Philadelphia, PA 19106-3621, USA. Keywords: United States, York, Acid Reflux, Barrett Esophagus, Barrett Syndrome, Esophageal, Gastroenterology, Gastroesophageal Reflux Disease. This article was prepared by Gastroenterology Week editors from staff and other reports. Copyright 2009, Gastroenterology Week via NewsRx.com.
|
